WHO SEARN Recognises IPC as Regional Centre of Excellence
Indian Pharmacopoeia Commission (IPC) has been recognised by WHO SEARN as a Regional Centre of Excellence for pharmacovigilance and medicines quality.
Pharmaceutical Regulation | 06/08/2026 | By News Bureau
India to Build Future-Ready Drug Regulatory Framework: J P Nadda
India will build a future-ready drug regulatory framework, with the Central Drugs Standard Control Organisation (CDSCO) set to launch an end-to-end digital regulatory platform within 18 months.
Pharmaceutical Regulation | 01/08/2026 | By News Bureau
NMPA Reviews QMS for Vaccine and Drug GMP Compliance
China's NMPA has completed a QMS management review to strengthen vaccine and drug Good Manufacturing Practice (GMP) compliance, supporting WHO WLA standards and PIC/S regulatory requirements.
Pharmaceutical Regulation | 13/07/2026 | By News Bureau
Government Revises Drugs Rules to Regulate High Alcohol-Content Medicines
India has strengthened regulation of high alcohol-containing drug formulations by bringing products with over 12 percent v/v ethyl alcohol under Schedule H1 and ending their Schedule K exemption.
Pharmaceutical Regulation | 10/07/2026 | By News Bureau | 163
EMA Expands PRIME Programme with New Tools to Accelerate Drug Development
EMA introduces three new features to its PRIME scheme, enhancing regulatory support, speeding scientific advice, and improving readiness for marketing authorisation submissions.
Pharmaceutical Regulation | 21/03/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy